Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer01:27

Peptic Ulcer

30
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
30
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

1.0K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.0K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

2.7K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.7K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

1.5K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.5K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

787
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
787
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

769
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
769

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical outcomes in gallbladder cancer: evidence from the UK nationwide CAPBIL study.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same author

The increasing burden of alcohol-related traumatic brain injury in older adults - Two decades of population-based data from Southwestern Norway.

Brain & spine·2026
Same author

Rectal syphilis presenting as a bleeding rectal tumour.

Journal of surgical case reports·2026
Same author

Evaluation of the trauma criteria from the Norwegian national trauma plan: an observational study from a regional trauma centre.

Scandinavian journal of trauma, resuscitation and emergency medicine·2026
Same author

Exploring the Relationship between Dietary Intake and Clinical Outcomes in Peritoneal Dialysis Patients Stratified by Serum Albumin Levels: A 12-Year Follow-Up Using Fine-Grained Electronic Medical Records Data.

Health data science·2026
Same author

The effect of delays in cancer surgery due to the COVID-19 pandemic on cancer resectability and postoperative mortality in different tumor entities.

Discover oncology·2026

Related Experiment Video

Updated: Apr 1, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.7K

Perforated peptic ulcer.

Kjetil Søreide1, Kenneth Thorsen2, Ewen M Harrison3

  • 1Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Lancet (London, England)
|October 14, 2015
PubMed
Summary

Perforated peptic ulcer management requires early surgery and sepsis control. More high-quality trials are needed to improve clinical decision-making and reduce high mortality rates for this common emergency.

More Related Videos

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
07:32

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance

Published on: December 3, 2020

6.6K
Application of Simplified Stent-bridging Pancreaticogastrostomy in Open Pancreaticoduodenectomy
10:09

Application of Simplified Stent-bridging Pancreaticogastrostomy in Open Pancreaticoduodenectomy

Published on: March 17, 2026

203

Related Experiment Videos

Last Updated: Apr 1, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.7K
An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
07:32

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance

Published on: December 3, 2020

6.6K
Application of Simplified Stent-bridging Pancreaticogastrostomy in Open Pancreaticoduodenectomy
10:09

Application of Simplified Stent-bridging Pancreaticogastrostomy in Open Pancreaticoduodenectomy

Published on: March 17, 2026

203

Area of Science:

  • Gastroenterology
  • Emergency Medicine
  • Surgical Research

Background:

  • Perforated peptic ulcer (PPU) is a critical global emergency with up to 30% mortality.
  • Limited high-quality studies hinder optimal clinical decision-making for PPU.
  • Demographic and etiological variations exist globally, impacting PPU outcomes.

Purpose of the Study:

  • To summarize current evidence on perforated peptic ulcer management.
  • To identify research gaps and future directions for clinical trials in PPU.

Main Methods:

  • Review of available randomized trials and published literature on PPU.
  • Analysis of factors influencing PPU demographics, causes, and mortality.
  • Assessment of current management strategies including surgical and non-operative approaches.

Main Results:

  • Early surgical intervention (laparoscopic or open repair) and sepsis management are crucial for PPU.
  • Non-operative and endoscopic approaches show promise but require further trial validation.
  • Clinical prediction rule accuracy varies, necessitating improved evidence.

Conclusions:

  • High-quality, low-bias trials are urgently needed to advance PPU management evidence.
  • Further research should focus on optimizing sepsis care bundles and postoperative monitoring.
  • Standardizing PPU care globally requires robust clinical trial data.